THE ROLE OF TURMERIC TABLETS IN ALLEVIATING INFLAMMATION AND OXIDATIVE STRESS IN CHRONIC KIDNEY DISEASE PATIENTS

Authors

  • POLLOB KUMER ROY Department of Pharmaceutics, Datta Meghe College of Pharmacy, Datta Meghe Institute of Higher Education and Research (Deemed to be University), Sawangi (Meghe), Wardha, Maharashtra, India. https://orcid.org/0009-0005-9920-789X
  • CHANDAN KUMAR Department of Pharmaceutics, Datta Meghe College of Pharmacy, Datta Meghe Institute of Higher Education and Research (Deemed to be University), Sawangi (Meghe), Wardha, Maharashtra, India.
  • SHITAL A CHANDEWAR Department of Pharmaceutics, Datta Meghe College of Pharmacy, Datta Meghe Institute of Higher Education and Research (Deemed to be University), Sawangi (Meghe), Wardha, Maharashtra, India.

DOI:

https://doi.org/10.22159/ajpcr.2025v18i12.54264

Keywords:

Curcumin, Turmeric tablets, Chronic kidney disease, Inflammation, Oxidative stress, Nuclear factor erythroid 2 activation, Clinical efficacy

Abstract

chronic kidney disease is a progressive condition characterized by ongoing inflammation and oxidative stress. which plays an essential role in pathophysiology and complications Recent studies highlight the possible therapeutic role of curcumin, the active compound in turmeric, in preventing these harmful processes. The effects of turmeric tablets have been evaluated in terms of their mechanism of action. Clinical efficacy and safety There is substantial evidence that curcumin supplementation is positively associated with TNF-α, IL-6, and C-reactive protein, and improving antioxidant activity by inducing erythrocyte nuclear factor2.It is associated with a reduction in inflammatory cytokines. However, curcumin's effects on traditional markers of kidney function remain controversial. Most studies reported no change in GFR or serum creatinine. Further studies will be necessary to establish an optimal dosing plan and dosing regimen to increase bioavailability and therapeutic activity. Overall, curcumin is a potential adjuvant therapy for managing inflammation and stress from Oxidative reactions in patients with chronic kidney disease and deserves further study in a clinical environment.

Downloads

Download data is not yet available.

References

1. Becker GJ, Hewitson TD. Animal models of chronic kidney disease: Useful but not perfect. Nephrol Dial Transplant. 2013;28:2432-8.

2. Chronic Kidney Disease - Symptoms and Causes. Mayo Clinic Publications. Available from: https://www.mayoclinic.org/diseases/ conditions/chronic/kidney/disease/symptoms/causes/syc/20354521 [Last accessed on 2025 Jan 06].

3. Chronic Kidney Disease (CKD): Symptoms and Treatment. Cleveland Clinic. Available from: https://my.clevelandclinic.org/health/ diseases/15096/chronic/kidney/disease [Last accessed on 2025 Jan 06].

4. Ghosh SS, Gehr TW, Ghosh S. Curcumin and chronic kidney disease (CKD): Major mode of action through stimulating endogenous intestinal alkaline phosphatase. Molecules. 2014;19:20139-56.

5. MSD Manual Professional Edition. Chronic Kidney Disease - Genitourinary Disorders. Available from: https://www. msdmanuals.com/professional/genitourinary/disorders/chronic/kidney/ disease/chronic/kidney/disease [Last accessed on 2025 Jan 06].

6. Ghosh SS, Gehr TW, Ghosh S. Curcumin and chronic kidney disease (CKD): Major mode of action through stimulating endogenous intestinal alkaline phosphatase. Molecules. 2014 Dec 2;19(12):20139-56. doi: 10.3390/molecules191220139, PMID 25474287

7. Weir MA, Walsh M, Cuerden MS, Sontrop JM, Urquhart BL, Lim YJ, et al. The effect of micro-particle curcumin on chronic kidney disease progression: The MPAC-CKD randomized clinical trial. Nephrol Dial Transplant. 2023 Sep 29;38(10):2192-200. doi: 10.1093/ndt/gfad037, PMID 36849161

8. Liang J, Liu Y. Animal models of kidney disease: Challenges and perspectives. Kidney360. 2023;4(10):1479-93. doi: 10.34067/ KID.0000000000000227, PMID 37526653

9. Fogo AB. Mechanisms of progression of chronic kidney disease. Pediatr Nephrol. 2007;22(12):2011-22. doi: 10.1007/s00467-007- 0524-0, PMID 17647026

10. Garcia Sanchez JJ, Thompson J, Scott DA, Evans R, Rao N, Sörstadius E, et al. Treatments for chronic kidney disease: A systematic literature review of RCT s. Adv Ther. 2021 Dec 8;39(1):193-220. doi: 10.1007/s12325-021-02006-z, PMID 34881414

11. Bagherniya M, Soleimani D, Rouhani MH, Askari G, Sathyapalan T, Sahebkar A. The use of curcumin for the treatment of renal disorders: A systematic review of randomized controlled trials. Adv Exp Med Biol. 2021;1291:327-43. doi:

12. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: Problems and promises. Mol Pharm. 2007;4(6):807-18. doi: 10.1021/mp700113r, PMID 17999464

13. Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice. Cancer Res Treat. 2014 Jan;46(1):2-18. doi: 10.4143/crt.2014.46.1.2, PMID 24520218

14. Tabanelli R, Brogi S, Calderone V. Improving curcumin bioavailability: Current strategies and future perspectives. Pharmaceutics. 2021 Oct 17; 13(10):1715. doi: 10.3390/pharmaceutics13101715, PMID 34684008

15. Mimica B, Bučević Popović V, Banjari I, Jeličić Kadić A, Puljak L. Methods used for enhancing the bioavailability of oral curcumin in randomized controlled trials: A meta research study. Pharmaceuticals (Basel). 2022 Jul 28;15(8):939. doi: 10.3390/ph15080939, PMID 36015087

16. Pivari F, Mingione A, Piazzini G, Ceccarani C, Ottaviano E, Brasacchio C, et al. Curcumin supplementation (Meriva®) modulates inflammation, lipid peroxidation and gut microbiota composition in chronic kidney disease. Nutrients. 2022;14(1):231. doi: 10.3390/ nu14010231, PMID 35011106

17. Hegde M, Girisa S, BharathwajChetty B, Vishwa R, Kunnumakkara AB. Curcumin formulations for better bioavailability: What we learned from clinical trials thus far? ACS Omega. 2023 Sep 29;8(12):10713-46. doi: 10.1021/acsomega.2c07326, PMID 37008131

18. Weir MA, Walsh M, Cuerden MS, Sontrop JM, Chambers LC, Garg AX. Micro-particle curcumin for the treatment of chronic kidney disease-1: Study protocol for a multicenter clinical trial. Can J Kidney Health Dis. 2018 Dec 5;5:2054358118813088. doi: 10.1177/2054358118813088, PMID 30619615

19. What are the Negative Effects of Turmeric? Who Shouldn’t Take it? Available from: https://www.medicinenet.com/what_are_the_negative_ effects_of_turmeric/article.htm[Last accessed on 2025 Jan 08].

20. Turmeric: Benefits, Side Effects, and More. MedicalNewsToday. Available from: https://www.medicalnewstoday.com/articles/318405 [Last accessed on 2025 Jan 08].

21. What are the Side Effects of Too Much Tumeric? Healthline. Available from: https://www.healthline.com/nutrition/turmeric-side-effects [Last accessed on 2025 Jan 08].

22. GitHub. Growth-Leaderships/Turmeric Supplement Market Key Drivers and Forecast; 2025-2032.md at main snehabhujbal/Growth- Leaderships. Available from: https://github.com/snehabhujbal/growth/ leaderships/blob/main/turmeric%20supplement%20market%20 key%20drivers%20and%20forecast%202025-2032.md [Last accessed on 2025 Jan 09].

Published

07-12-2025

How to Cite

POLLOB KUMER ROY, et al. “THE ROLE OF TURMERIC TABLETS IN ALLEVIATING INFLAMMATION AND OXIDATIVE STRESS IN CHRONIC KIDNEY DISEASE PATIENTS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 18, no. 12, Dec. 2025, pp. 10-17, doi:10.22159/ajpcr.2025v18i12.54264.

Issue

Section

Review Article(s)